Atlas Trials

Stage IV or Recurrent Non-Small Cell Lung Cancer

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV or Recurrent Non-Small Cell Lung Cancer

RecordFirmDate
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) (NCT02041533)Bristol-Myers Squibb2014-03-27

Track Stage IV or Recurrent Non-Small Cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.